Carmela M. Reichel

Carmela M. Reichel

Auto-generated profile, based on publicly available information

Carmela M. Reichel

Department of Neuroscience, Medical University of South Carolina, Charleston, SC 29425, United States

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KMKhaled Moussawi
Khaled Moussawi
WZWenhua Zhou
Wenhua Zhou
HSHaowei Shen
Haowei Shen
CRCarmela M. Reichel
Carmela M. Reichel
RSRonald E. See
Ronald E. See
PKPeter W. Kalivas
Peter W. Kalivas
Cocaine addiction remains without an effective pharmacotherapy and is characterized by an inability of addicts to inhibit relapse to drug use. Vulnerability to relapse arises from an enduring impairment in cognitive control of motivated behavior, manifested in part by dysregulated synaptic potentiation and extracellular glutamate homeostasis in the projection from the prefrontal cortex to the nucleus accumbens. Here we show in rats trained to self-administer cocaine that the enduring cocaine-induced changes in synaptic potentiation and glutamate homeostasis are mechanistically linked through group II metabotropic glutamate receptor signaling. The enduring cocaine-induced changes in measures of cortico-accumbens synaptic and glial transmission were restored to predrug parameters for at least 2 wk after discontinuing chronic treatment with the cystine prodrug,N-acetylcysteine.N-acetylcysteine produced these changes by inducing an enduring restoration of nonsynaptic glutamatergic tone onto metabotropic glutamate receptors. The long-lasting pharmacological restoration of cocaine-induced glutamatergic adaptations by chronicN-acetylcysteine also caused enduring inhibition of cocaine-seeking in an animal model of relapse. These data mechanistically link nonsynaptic glutamate to cocaine-induced adaptations in excitatory transmission and demonstrate a mechanism to chronically restore prefrontal to accumbens transmission and thereby inhibit relapse in an animal model.

1 October 2013 in Psychoneuroendocrinology
Verified
Journal Article
Open access
BCBrittney M. Cox
Brittney M. Cox
AYAmy B. Young
Amy B. Young
RSRonald E. See
Ronald E. See
CRCarmela M. Reichel
Carmela M. Reichel
Previous evidence in an animal model of drug self-administration and drug seeking showed that acute oxytocin decreased methamphetamine (meth) seeking in male rats, suggesting potential clinical efficacy for the treatment of psychostimulant addiction. However, based on the well-established role of oxytocin in reproduction and pair bond formation, it is important to know how this effect extrapolates to females. Here, we tested whether oxytocin (1mg/kg, IP) would decrease meth seeking in female rats across various stages of the estrous cycle (Experiment 1). Freely cycling Long Evans female rats self-administered meth (IV) in 2-h daily sessions, followed by daily extinction sessions. Following extinction, rats received oxytocin (0, 0.3, or 1mg/kg, IP) 30min before a meth priming injection (1mg/kg, IP) to assess reinstatement of meth seeking. Next, we examined the effects of oxytocin on motivated meth- and sucrose-taking and seeking in male and female rats. In separate experiments, males and females self-administered meth (Experiment 2) or sucrose (Experiment 3) until responding was stabilized along a fixed ratio (FR) 5 schedule of reinforcement. Subsequently, rats received either oxytocin or vehicle prior to self-administration along a progressive ratio (PR) schedule of reinforcement. Rats were subsequently tested for cue-, meth-, and stress-induced reinstatement after pretreatment with oxytocin or vehicle. While oxytocin reduced meth seeking in females, we found that estrous cycle stage (as determined from vaginal cytology) did not influence meth-primed reinstatement or the ability of oxytocin to decrease reinstatement of meth seeking. Oxytocin reduced PR responding for meth only in females. Females responded more than males during cue-induced reinstatement of meth and sucrose seeking, and oxytocin reduced this responding only in meth females. In both sexes, oxytocin attenuated meth seeking in response to a meth prime and yohimbine (a pharmacological stressor). The results suggest that oxytocin may have efficacy as a treatment of meth addiction in both sexes; however, females may show greater response to oxytocin treatment for the prevention of relapse.

17 May 2012 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
CRCarmela M. Reichel
Carmela M. Reichel
CCClifford H. Chan
Clifford H. Chan
SGShannon M. Ghee
Shannon M. Ghee
RSRonald E. See
Ronald E. See

8 December 2010 in Neuropsychopharmacology
Verified
Journal Article
Closed access
CRCarmela M Reichel
Carmela M Reichel
MSMarek Schwendt
Marek Schwendt
JMJacqueline F McGinty
Jacqueline F McGinty
FOFoster Olive
Foster Olive
RSRonald See
Ronald See

1 May 2011 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
PDF file
CRCarmela M. Reichel
Carmela M. Reichel
KMKhaled Moussawi
Khaled Moussawi
PDPhong H. Do
Phong H. Do
PKPeter W. Kalivas
Peter W. Kalivas
RSRonald See
Ronald See
The cysteine prodrug N-acetylcysteine (NAC) has been shown to reduce reinstatement of cocaine seeking by normalization of glutamatergic tone. However, enduring inhibition of cocaine seeking produced by NAC has not been explored under different withdrawal conditions. Thus, the present study determined whether chronic NAC administered during daily extinction training or daily abstinence after withdrawal from cocaine self-administration would reduce cocaine seeking. Rats self-administered intravenous cocaine during daily 2-h sessions for 12 days, followed by daily extinction or abstinence sessions. During this period, rats received daily injections of saline or NAC (60 or 100 mg/kg). Subsequently, rats were tested for cocaine seeking via conditioned cue, cue + cocaine-primed, and context-induced relapse. Chronic NAC administration blunted cocaine seeking under multiple experimental protocols. Specifically, NAC attenuated responding during cue and cue + cocaine-primed reinstatement tests after extinction and context, cue, and cue + cocaine relapse tests after abstinence. Protection from relapse by NAC persisted well after treatment was discontinued, particularly when the high dose was combined with extinction trials. The finding that NAC reduced cocaine seeking after drug treatment was discontinued has important implications for the development of effective antirelapse medications. These results support recent preclinical and clinical findings that NAC may serve as an effective treatment for inhibiting relapse in cocaine addicts.

1 October 2016 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
ABAurelien Bernheim
Aurelien Bernheim
RSRonald E. See
Ronald E. See
CRCarmela M. Reichel
Carmela M. Reichel